FMP
Virtus LifeSci Biotech Products ETF
BBP
AMEX
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.
61.01 USD
0.9917 (1.63%)
About
ceo
N/A
sector
Financial Services
industry
Asset Management
website
N/A
exchange
AMEX
Description
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.
CIK
0001559109
ISIN
US26923G2021
CUSIP
26923G202
Address
N/A
Phone
NA
Country
US
Employee
N/A
IPO Date
Dec 17, 2014
Key Executives
